Whole Pelvic Irradiation for Patients With Prostate Cancer With a Biochemical Relapse Following Radical Prostatectomy: The Era of Robot-Assisted Minimally Invasive Surgery

Abstract

DMFS, CSS and OS are summarized in the table below for all three groups when compared to aRT. None of the men in the HR group experienced BC at 5 years. Pairwise comparisons of outcomes between the aRT and FR groups demonstrated no significant differences. Conclusions: Our analysis identified a group of FR men treated with sRT who had outcomes comparable to men treated with aRT. Our risk grouping identified IR and HR groups who may be good candidates for clinical trials that incorporate systemic therapies aimed at improving DMFS, CSS and the efficacy of sRT.